SEC Form 4 · accession 0001140361-17-044019
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Pendarvis
Officer — Chief Administrative Officer
Period of report
Nov 27, 2017
Accepted (ET)
Nov 28, 2017 · 6:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF2 | Nov 27, 2017 | A | 7,666 | $84.63 | A | 98,454 | D | |
| ResMed Common StockF3 | Nov 27, 2017 | F | 4,001 | $84.63 | D | 94,453 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares acquired on vesting of performance-based restricted stock units. The PSUs were granted November 19, 2014, with a three-year performance period. The shares were earned and vested November 27, 2017, when the ResMed compensation committee certified performance.
- F2Shares earned based on performance at 57% of the target award.
- F3Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2014.